SARS-CoV-2-ORF-3a Mediates Apoptosis Through Mitochondrial Dysfunction Modulated by the K+ Ion Channel
Muhammad Suhaib Qudus1, Uzair Afaq1, Siyu Liu1
1State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
Abstract:
Coronavirus disease 2019 (COVID-19) causes pulmonary edema, which disrupts the lung alveoli-capillary barrier and leads to pulmonary cell apoptosis, the main cause of death. However, the molecular mechanism behind SARS-CoV-2's apoptotic activity remains unknown. Here, we revealed that SARS-CoV-2-ORF-3a mediates the pulmonary pathology associated with SARS-CoV-2, which is demonstrated by the fact that it causes lung tissue damage. The in vitro results showed that SARS-CoV-2-ORF-3a triggers cell death via the disruption of mitochondrial homeostasis, which is modulated through the regulation of Mitochondrial ATP-sensitive Potassium Channel (MitoKATP). The addition of exogenous Potassium (K+) in the form of potassium chloride (KCl) attenuated mitochondrial apoptosis along with the inflammatory interferon response (IFN-β) triggered by SARS-ORF-3a. The addition of exogenous K+ strongly suggests that dysregulation of K+ ion channel function is the central mechanism underlying the mitochondrial dysfunction and stress response induced by SARS-CoV-2-ORF-3a. Our results designate that targeting the potassium channel or its interactions with ORF-3a may represent a promising therapeutic strategy to mitigate the damaging effects of infection with SARS-CoV-2.
Insights
Severe COVID-19 lung damage is caused by the SARS-CoV-2 ORF-3a protein disrupting mitochondrial function. Restoring potassium levels can mitigate this damage and inflammation, suggesting new therapeutic targets.
Area of Science:
- Virology
- Cellular Biology
- Pathology
Background:
- COVID-19, caused by SARS-CoV-2, leads to severe lung damage and cell death.
- The precise molecular mechanisms driving SARS-CoV-2-induced apoptosis remain unclear.
- Pulmonary edema and alveolar-capillary barrier disruption are key pathological features.
Purpose of the Study:
- To elucidate the molecular mechanisms of SARS-CoV-2-induced pulmonary cell apoptosis.
- To identify the role of SARS-CoV-2 ORF-3a protein in COVID-19 pathology.
- To investigate potential therapeutic targets for mitigating SARS-CoV-2 lung injury.
Main Methods:
- In vitro studies using SARS-CoV-2 ORF-3a.
- Analysis of mitochondrial homeostasis and apoptosis pathways.
- Assessment of the impact of exogenous potassium (K+) on cellular responses.
Main Results:
- SARS-CoV-2 ORF-3a was identified as a mediator of lung tissue damage.
- ORF-3a disrupts mitochondrial homeostasis by regulating the Mitochondrial ATP-sensitive Potassium Channel (MitoKATP).
- Exogenous potassium (K+) addition attenuated ORF-3a-induced mitochondrial apoptosis and interferon-beta (IFN-β) response.
Conclusions:
- Dysregulation of potassium ion channel function is central to SARS-CoV-2 ORF-3a-induced mitochondrial dysfunction.
- Targeting potassium channels or their interaction with ORF-3a presents a promising therapeutic strategy.
- This research offers insights into mitigating the severe lung pathology associated with SARS-CoV-2 infection.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
01:17The Extrinsic Apoptotic Pathway
01:30Apoptosis
01:24Caspases
01:18Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...